previous compound ID: 147 next compound
InChIKey: ALLWOAVDORUJLA-UHFFFAOYSA-N
SMILES: C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Goepp" "GW Carlile" "B Kus" "SD Macknight" "R Robert" "DY Thomas" "E Matthes" "D Rotin" "JW Hanrahan" "J Liao"

chemical graph of compound 147





CID is 5042
synonyms found at PubChem are:
rebamipide, 90098-04-7, Mucosta, Proamipide, 111911-87-6, OPC-12759, Rebamipidum, Pramipide, Rebamipide [INN:JAN], Rebamipidum [INN-Latin], Rebamipida [INN-Spanish], OPC 12759, CCRIS 3585, Rebamipide hydrate, 2-(4-Chlorobenzoylamino)-3-(1,2-dihydro-2-oxo-4-quinolyl)propionic acid, 2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid, Mucosta hydrate, 139344-42-6, NCGC00095161-01, Proamipide hydrate, 2-(4-chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid, (+-)-2-(4-Chlorobenzoylamino)-3-(2(1H)-quinolinon-4-yl)propionic acid, (+-)-1,2-Dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-4-quinolinepropanoic acid, (+-)-alpha-((4-Chlorobenzoyl)amino)-1,2-dihydro-2-oxo-4-quinolinepropanic acid, 4-Quinolinepropanic acid, alpha-((4-chlorobenzoyl)amino)-1,2-dihydro-2-oxo-, (+-)-, DSSTox_CID_25937, DSSTox_RID_81235, DSSTox_GSID_45937, OPC 12759 hydrate, Rebamipida, 2-(4-Chlorobenzamido)-3-[2(1H)-quinolinon-4-yl]propionic Acid, 2-(4-chlorobenzoylamino)-3-(2(1H)-quinolinon-4-yl)propionic acid, 2-[[(4-chlorophenyl)-oxomethyl]amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid, 4-Quinolinepropanoic acid, 1,2-dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-, (+-)-, CAS-90098-04-7, SR-05000001520, C19H15ClN2O4, 2-(4-chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl]propionic acid, N-[(4-chlorophenyl)carbonyl]-3-(2-oxo-1,2-dihydroquinolin-4-yl)alanine, 2-[(4-chlorophenyl)carbonylamino]-3-(2-oxidanylidene-1H-quinolin-4-yl)propanoic acid, Mucosta (TN), AC1L1JHF, Spectrum2_000039, Spectrum3_001959, D03BQP, Rebamipide (JP17/INN), BSPBio_003559, GTPL871, MLS006011883, SCHEMBL221527, SPECTRUM1505310, SPBio_000137, QUI103, rebamipide 111911-87-6, CHEMBL1697771, DTXSID8045937, CHEBI:93814, CTK8B3342, KBio3_002880, KS-00000SHL, AOB5606, OPC-759, ALLWOAVDORUJLA-UHFFFAOYSA-N, MolPort-000-781-642, MolPort-003-666-633, HMS1922B20, HMS2090L13, HMS3655L11, HMS3714A15, Pharmakon1600-01505310, BCP07230, HY-B0360, Tox21_111460, ANW-42341, BBL011328, CCG-39619, CR0013, MFCD11114396, NSC758955, s2032, STK577121, STL146407, (+-)-alpha-(p-Chlorobenzamido)-1,2-dihydro-2-oxo-4-quinolinepropionic acid, AKOS005501649, AKOS005721106, Tox21_111460_1, 111911-87-6 (anhyd.), AC-6841, AC-7588, AN-9620, CS-2416, DB11656, MCULE-3675104222, NSC-758955, 2-(4-chloro-benzoylamino)-3-(2-oxo-1,2-dihydro-quinolin-4-yl)-propionic acid, NCGC00095161-02, NCGC00095161-03, NCGC00095161-04, NCGC00095161-05, AN-35058, SC-15936, SMR003309276, SBI-0207054.P001, AB0073108, AB1009629, LS-142127, LS-142128, FT-0630971, FT-0655225, R0085, D01121, AB01275518-01, AB01275518_02, AB01275518_03, 911R876, A802443, A843443, I14-0511, Q-201660, SR-05000001520-1, SR-05000001520-2, SR-05000001520-3, BRD-A15909516-001-02-5, BRD-A15909516-001-03-3, 2-(4-chlorobenzoylamino)-3-(2-quinolon-4-yl)propionic acid, 2-(4-chlorobenzoylamino)-3-[2(1h)-quinolinon-4-yl] propionic acid, N-[(4-chlorophenyl)carbonyl]-3-(2-hydroxyquinolin-4-yl)alanine, 2-(4-chlorobenzoylamino)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propionic acid, 4-Quinolinepropanoic acid, |A-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-, (+/-)-2-(4-CHLOROBENZOYLAMINO)-3-(2(1H)-QUINOLINON-4-YL)-PROPIONIC ACID, 4-Quinolinepropanoic acid, 1,2-dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-,(+-)-, alpha-[(4-Chlorobenzoyl)amino]-1,2-dihydro-2-oxo-4-quinolinepropanoic acid hydrate